0.7295
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
9 Overlooked Growth Stocks to Buy - Insider Monkey
Morgan Stanley reduces PT on Tenaya Therapeutics (TNYA), keeps constructive stance on US small- to mid-cap biotech - MSN
Morgan Stanley Reduces PT on Tenaya Therapeutics (TNYA), Keeps Constructive Stance on U.S. Small- to Mid-Cap Biotech - Insider Monkey
Tenaya Therapeutics appoints new interim principal accounting officer - MSN
10 Stocks Under $1 That Will Explode - Insider Monkey
What catalysts could drive Tenaya Therapeutics Inc. stock higher2025 Trading Volume Trends & Fast Entry High Yield Tips - Улправда
Will Tenaya Therapeutics Inc. stock benefit from infrastructure spending2025 Macro Impact & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Tenaya Therapeutics announces 2026 strategic priorities - MarketScreener
Tenaya Therapeutics Outlines 2026 Milestones Following Positive Interim Results from MyPEAK™-1 and RIDGE™-1 Trials - Quiver Quantitative
Gene therapy trials for inherited heart disease face big 2026 tests - Stock Titan
Is Tenaya Therapeutics Inc. stock supported by strong fundamentalsInflation Watch & Proven Capital Preservation Tips - ulpravda.ru
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones - Yahoo Finance
Why Tenaya Therapeutics Inc. stock could see breakout soonJuly 2025 Drop Watch & Consistent Income Trade Recommendations - Улправда
Published on: 2026-01-09 09:18:13 - Улправда
What insider trading reveals about Tenaya Therapeutics Inc. stockEntry Point & Consistent Return Investment Signals - Улправда
Published on: 2026-01-09 03:34:26 - Bộ Nội Vụ
Why Tenaya Therapeutics Inc. stock is trending among retail tradersJuly 2025 Rallies & Free Accurate Trade Setup Notifications - Улправда
How Tenaya Therapeutics Inc. stock reacts to Fed rate cutsEarnings Beat Highlights & Affordable Portfolio Building - ulpravda.ru
Tenaya Therapeutics announces orderly board leadership transition - MSN
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Buy Signal: Is Tenaya Therapeutics Inc stock supported by strong fundamentalsPortfolio Update Report & Daily Volume Surge Signals - moha.gov.vn
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Gene therapy genie back in the bottle? - BioWorld MedTech
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord - MSN
Why Tenaya Therapeutics Inc. stock is rated strong buy2025 Price Momentum & Free Expert Verified Stock Movement Alerts - Bölüm Sonu Canavarı
Tenaya Therapeutics, Inc.(NasdaqGS: TNYA) added to NASDAQ Biotechnology Index - MarketScreener
Buyout Rumor: Why Tenaya Therapeutics Inc stock is recommended by analystsMarket Activity Report & Reliable Trade Execution Plans - moha.gov.vn
Is International Seaways Inc stock attractive for ETFsMarket Risk Analysis & Smart Money Movement Tracker - moha.gov.vn
Leerink Partners Reaffirms Their Buy Rating on Tenaya Therapeutics (TNYA) - The Globe and Mail
Will Tenaya Therapeutics Inc. stock outperform growth indexesWeekly Market Outlook & Long Hold Capital Preservation Plans - Улправда
Is Tenaya Therapeutics Inc. stock positioned for long term growth2025 Performance Recap & Low Drawdown Momentum Ideas - Улправда
Will Tenaya Therapeutics Inc. stock remain a Wall Street favorite2025 Top Gainers & Consistent Profit Trading Strategies - DonanımHaber
Will Tenaya Therapeutics Inc. stock deliver shareholder valueQuarterly Investment Review & Expert-Curated Trade Recommendations - DonanımHaber
Canaccord Genuity Keeps Their Buy Rating on Tenaya Therapeutics (TNYA) - The Globe and Mail
Tenaya Therapeutics stock price target lowered to $5 at Canaccord By Investing.com - Investing.com Canada
FY2025 Earnings Forecast for TNYA Issued By Lifesci Capital - MarketBeat
Tenaya Therapeutics stock price target lowered to $5 at Canaccord - Investing.com India
Wilson Sonsini Advises Tenaya Therapeutics on Pricing of Public Offering - Wilson Sonsini
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data By Investing.com - Investing.com Australia
Tenaya fundraising follows resolution of clinical hold - The Pharma Letter
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data - Investing.com Nigeria
Tenaya Therapeutics announces proposed public offering - MSN
Tenaya Therapeutics price target lowered to $3 from $5 at HC Wainwright - MSN
자본화:
|
볼륨(24시간):